|
Re: Yes , it seems like a hundred years ago...
|
8
|
Resverlogix Corp.
|
Mar 08, 2021 10:55AM
|
|
Re: Yet another potential indication: Reduction of drug-seeking behavior
|
4
|
Resverlogix Corp.
|
Oct 26, 2021 06:44PM
|
|
Re: Zacks Buy Ranking
|
4
|
Resverlogix Corp.
|
Nov 04, 2015 12:42PM
|
|
Re: Zacks SCR Report 6/14/17
|
2
|
Resverlogix Corp.
|
Jun 18, 2017 11:58AM
|
|
Re: Zacks SCR Resverlogix Report 12/28/18
|
1
|
Resverlogix Corp.
|
Feb 26, 2019 03:59PM
|
|
Re: ZCC relationship to ZEL!
|
4
|
Zenith Epigenetics
|
Apr 13, 2019 01:53PM
|
|
Re: ZEN-3694 in combination with "enzalutamide" in patients with metastatic castration resistant prostate cancer (mCRPC)
|
4
|
Zenith Epigenetics
|
Aug 27, 2021 06:18PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
2
|
Zenith Epigenetics
|
Oct 26, 2017 10:24AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Sep 22, 2017 03:36PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 20, 2017 08:48PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 21, 2017 06:21AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Jul 15, 2017 12:58PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Jul 19, 2017 04:00PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Jul 18, 2017 03:19PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Sep 18, 2017 01:28PM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
1
|
Zenith Epigenetics
|
Apr 13, 2018 03:00PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
5
|
Zenith Epigenetics
|
Mar 14, 2016 06:45PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
3
|
Zenith Epigenetics
|
Mar 15, 2016 06:56PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
3
|
Zenith Epigenetics
|
Mar 10, 2016 01:45PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
4
|
Zenith Epigenetics
|
Mar 10, 2016 03:49PM
|
